357 search results for “taal immune responses” in the Staff website
-
Jos BrosschotFaculty of Social and Behavioural Sciences
brosschot@fsw.leidenuniv.nl | 071 5272727
-
Walter Nkwi GamFaculty of Humanities
w.nkwi.gam@hum.leidenuniv.nl | 071 5272322
-
Frederic LensFaculty of Science
f.p.lens@biology.leidenuniv.nl | 071 5272727
-
Peter VerhaarFaculty of Humanities
p.a.f.verhaar@library.leidenuniv.nl | 071 5278881
-
Klaas VrielingFaculty of Science
k.vrieling@biology.leidenuniv.nl | 071 5272727
-
Manolis FragkiadakisFaculty of Humanities
m.fragkiadakis@hum.leidenuniv.nl | 071 5278059
-
Bernardo Ribeiro de AlmeidaFaculteit der Rechtsgeleerdheid
b.ribeiro.de.almeida@law.leidenuniv.nl | 071 5272727
-
Peter KlinkhamerFaculty of Science
p.g.l.klinkhamer@biology.leidenuniv.nl | 071 5272727
-
Jan SleutelsFaculty of Humanities
j.j.m.sleutels@phil.leidenuniv.nl | 071 5272007
-
Workshop Weighing the Options: How to (responsibly) include GenAI in your teaching
Didactics
-
Young researchers looking for partnerships in Indonesia
A number of young researchers recently took part in a knowledge mission to Indonesia, aiming to build a lasting relationship with the country. How did they find the trip, what did they do, and how are they creating new connections with scientists in Indonesia?
-
FAIR - From FAIR to FAIR2: Turning principles into practice for responsible, AI-ready data
Webinar with Q&A
-
‘We couldn't really celebrate our vaccine being approved, but we were over the moon’
On 11 March, pharmaceutical company Janssen received approval to launch its corona vaccine on the European market. This made Janssen the fourth company to be given the green light by the European Medicines Agency. As Lead of the Janssen Campus in the Netherlands, Biology alumnus Bart van Zijll Langhout…
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Atherosclerosis resembles an autoimmune disease. Marie Depuydt graduated on this topic, with honours
In addition to cholesterol and high blood pressure as risk factors for atherosclerosis, we may need to address our own immune system to prevent a heart attack or stroke. Marie Depuydt revealed which cells exactly reside in the atherosclerotic plaque that narrows an artery. The presence of a diverse…
-
Five Leiden contributions to NWO Perspectief projects
Five consortia within the Perspectief programme that include Leiden researchers have received funding to start their research projects. These projects focus on (further) developing technological innovations, with societal and economic impact at their core.
-
Medical milestone at LUMC: first Dutch patient receives CAR T-cell therapy for autoimmune disease
The LUMC has become the first institution in the Netherlands to treat a patient with an autoimmune disease using CAR T-cell therapy.
-
Vidi grants for 12 researchers from Leiden University
An impressive 12 researchers from Leiden University have been awarded an 800,000-euro grant by the Dutch Research Council (NWO). This will enable them to develop their own line of research over the next five years.
-
How drugs work better when encapsulated in nanoparticles
Chemist Tobias Bauer discovered ways to improve drugs by encapsulating them. Packages with iron nanoparticles, for example, can stimulate immune cells. Bauer will receive his PhD on 9 June.
-
Modified caffeine molecules help medical research move forward
Before researchers can develop targeted drugs, they need to know exactly how a disease works. Biochemist Bert Beerkens created molecules that allow them to find out. He used caffeine as the basis for new molecules that enable research into certain receptor proteins on cells.
-
Major Leiden symposium on TB bacteria
More than 1.3 million people worldwide die of tuberculosis (TB) each year, making research on its prevention and control essential. Researchers from various disciplines in Leiden are studying TB. A symposium on 24 March will highlight different activities in the hope of boosting nationwide collabora…
-
How can criminal law protect democracy?
Should criminal law have a greater role in protecting this democracy? In his inaugural lecture, Professor Jeroen ten Voorde urges caution.
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
‘Science isn’t about memorising a textbook’
How do you engage students? Sander van Kasteren knows how to do that like no other. ‘He compares immune cells to Pokémon and doesn’t just give information; he tells stories,’ students say about their favourite lecturer, Sander van Kasteren. The Professor of Molecular Immunology passionately teaches…
-
Leiden scientists create first-ever dengue-on-a-chip to study this deadly virus
Researchers at Leiden University have created a unique model that mimics how disease develops after a dengue infection. This 'dengue-on-a-chip' model helps them study the virus more effectively. The timing is crucial, as climate change is causing dengue to spread worldwide.
-
Leiden’s poo can help rid patients of resistant gut bacteria
Transferring poo from healthy donors to the intestines of chronically ill people has beneficial effects on these recipients’ gut bacteria, also in the longer term. This is the conclusion of research by the Leiden University Medical Center (LUMC) and the Netherlands Donor Feces Bank (NDFB).
-
Grants for fundamental research in Leiden
Three fundamental research projects at Leiden in physics, chemistry and medical science have received funding from the Dutch Research Council (NWO). They involve research on magnetic fields in the universe, the role of myeloid cells in cancer immunotherapy and the evolution of ancient proteins.
-
Sabine van der Asdonk wins Gratama Science Prize 2021
For her research into complex family problems, an assistant professor in Forensic Family and Youth Care Studies Sabine van der Asdonk has won the Gratama Science Prize 2021, a prize for talented young researchers from the universities of Leiden and Groningen. The jury praised Van der Asdonk’s excellent…
-
Silver and light: a powerful combination with the potential to save lives
Packages of DNA strands containing silver, measuring just two or three nanometres in size. Leiden physicists Donny de Bruin and Dirk Bouwmeester create these packages, which can enter living cells on their own. They then activate the silver with light, causing the cells to break down. This could, in…
-
Sander van Kasteren: from molecule builder to Professor of Chemical Immunology
Sander van Kasteren only noticed some small, subtle changes since he was appointed professor on 1 May. Still, he has to get used to the idea, even though he had been working towards the professorship for a few years. ‘I don't quite see myself as a professor yet.'
-
BioTherapeutics in new national AtheroNeth consortium
The Dutch Heart Foundation will fund a new nation-wide consortium, AtheroNeth, consisting of preclinical and clinical scientists in the field of atherosclerosis research. AtheroNeth aims to identify novel biomarkers that can be applied to stratify patient groups at risk for acute cardiovascular events…
-
Review on “Anticancer opportunities at every stage of chemokine function” is featured on the cover of TIPS
Last November, Dr. Natalia Ortiz, Martijn Bemelmans (MSc), and Prof. Laura Heitman published a review in Trends in Pharmacological Sciences (TIPS) on targeting the chemokine system in cancer (https://doi.org/10.1016/j.tips.2021.08.001). The review was written in collaboration with Prof. Tracy Handel…
-
Towards responsible and resilient mineral supply chains, with case studies on cobalt, antimony, and zinc
PhD defence
-
Navigating corporate responsibility in global supply chains using codes of conduct
PhD defence
-
Rudolf PoolmanFaculty of Medicine
r.w.poolman@lumc.nl | 071 5269111
-
Thijs van OschFaculty of Medicine
m.j.p.van_osch@lumc.nl | 071 5269111
-
Catherine MergenFaculty of Science
c.mergen@lacdr.leidenuniv.nl | 071 5276038
-
Martine JagerFaculty of Medicine
m.j.jager@lumc.nl | 071 5269111
-
Rob NelissenFaculty of Medicine
r.g.h.h.nelissen@lumc.nl | 071 5263606
-
Adam CohenFaculty of Medicine
ac@chdr.nl | 071 5269111
-
Ferry OssendorpFaculty of Medicine
f.a.ossendorp@lumc.nl | 071 5263800
-
Gerhard BurgerFaculty of Science
g.a.burger@lacdr.leidenuniv.nl | 071 5274285
-
Jelle GoemanFaculty of Medicine
j.j.goeman@lumc.nl | 071 5269700
-
Saskia le CessieFaculty of Medicine
s.le_cessie@lumc.nl | 071 5272124
-
Bram KosterFaculty of Medicine
a.j.koster@lumc.nl | 071 5269294
-
Pieter HiemstraFaculty of Medicine
p.s.hiemstra@lumc.nl | 071 5269111
-
Olaf DekkersFaculty of Medicine
o.m.dekkers@lumc.nl | 071 5269111
-
Discussions: Current trends in the study of government and community responses to jihadi insurgencies in Africa
Roundtable
-
Tanja Hendriks awarded Veni
The Dutch Research Council (NWO) has announced that Tanja Hendriks, along with 17 Leiden University researchers, will receive a Veni grant, embedded at the ASCL. With this grant, Hendriks will be able to develop the research project 'Taking a Risk on Disasters: speculative humanitarianism amidst a changing…
-
Historian Gert Oostindie the new Cleveringa Professor
Gert Oostindie, Emeritus Professor of Colonial and Postcolonial History, is this year’s Cleveringa Professor at Leiden University. He was appointed by the University on 4 October. In his inaugural lecture on 24 November, entitled Courage and Disregard, he will talk about (academic) freedom in relation…